Lamond Capital Partners as of Dec. 31, 2014
Portfolio Holdings for Lamond Capital Partners
Lamond Capital Partners holds 15 positions in its portfolio as reported in the December 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Infoblox | 19.8 | $30M | 1.5M | 20.21 | |
| Kite Pharma | 13.8 | $21M | 366k | 57.67 | |
| Bluebird Bio (BLUE) | 8.8 | $14M | 147k | 91.72 | |
| Rally Software Development | 8.7 | $13M | 1.2M | 11.37 | |
| Gilead Sciences (GILD) | 8.4 | $13M | 136k | 94.26 | |
| Orexigen Therapeutics | 7.5 | $12M | 1.9M | 6.06 | |
| Puma Biotechnology (PBYI) | 6.8 | $10M | 55k | 189.27 | |
| Gw Pharmaceuticals Plc ads | 6.0 | $9.1M | 134k | 67.68 | |
| BioMarin Pharmaceutical (BMRN) | 5.4 | $8.3M | 92k | 90.40 | |
| salesforce (CRM) | 5.0 | $7.6M | 128k | 59.31 | |
| Aol | 3.9 | $5.9M | 129k | 46.17 | |
| Ultragenyx Pharmaceutical (RARE) | 2.2 | $3.4M | 78k | 43.88 | |
| Ringcentral (RNG) | 1.6 | $2.4M | 161k | 14.92 | |
| Ocular Therapeutix (OCUL) | 1.1 | $1.7M | 74k | 23.51 | |
| Synageva Biopharma | 0.9 | $1.4M | 15k | 92.79 |
